AZELAIC ACID
Cette fiche confirme une dénomination commune officielle d’ingrédient pour l’étiquetage des produits cosmétiques de l’UE. Elle ne confirme pas à elle seule que la substance est autorisée, non restreinte ou sûre.
Aperçu des preuves mondiales
L’identité résolue présente des preuves réglementaires correspondantes dans 4 des 13 jeux de données de marchés indexés : 4 fiches de pays et 0 fiches d’annexes de l’UE. Chaque résultat et chaque lacune de preuves sont énumérés ci-dessous.
Identité résolue de la substance
5 noms correspondants ou signalés
Preuves réglementaires dans les 13 marchés
Ouvrez chaque fiche correspondante pour connaître son champ d’application, sa concentration, ses conditions, ses avertissements et la version de la source officielle.
Balayez ou faites défiler horizontalement pour voir la couverture des jeux de données et les actions suivantes.
| Marché | Résultat | Fiches | Jeu de données | Signification / action suivante |
|---|---|---|---|---|
| European Union EU | Aucune correspondance trouvée | 0 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review. |
| Great Britain GB | Aucune correspondance trouvée | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | Restricted | 1Ouvrir la fiche 1 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | Examinez chaque fiche associée et ses conditions exactes. |
| New Zealand NZ | Aucune correspondance trouvée | 0 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative. |
| ASEAN ASEAN | Prohibited | 1Ouvrir la fiche 1 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| China CN | Aucune correspondance trouvée | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | Aucune correspondance trouvée | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | Prohibited | 1Ouvrir la fiche 1 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Examinez chaque fiche associée et ses conditions exactes. |
| United States US | Aucune correspondance trouvée | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | Aucune correspondance trouvée | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | Aucune correspondance trouvée | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Aucune correspondance trouvée | 0 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | The standards are separate controlled publications; absence from a locally indexed excerpt is not permission. |
| Saudi Arabia SA | Restricted | 1Ouvrir la fiche 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | Examinez chaque fiche associée et ses conditions exactes. |
Fiches de marché correspondantes et conditions
ASEAN
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026South Korea
MFDS Notice 2026-19, effective 18 March 2026Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026Identité et propriétés chimiques

Azelaic Acid
Nonanedioic acid is an alpha,-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate and an azelaate(2-). — ChEBI
- Nom IUPAC
- nonanedioic acid
- Formule moléculaire
- C9H16O4
- Masse moléculaire
- 188.22 g/mol
- Masse exacte
- 188.10485899 Da
- XLogP3
- 1,6
- Surface polaire topologique
- 74,6 Ų
- Donneurs de liaisons hydrogène
- 2
- Accepteurs de liaisons hydrogène
- 4
- Unités covalentes
- 1
- Stéréocentres définis
- 0
Également connu sous le nom de
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:48131
- ChEMBL:CHEMBL1238
- EPA DTXSID:DTXSID8021640
- PubMed:22920095
- PubMed:22849351
- PubMed:22822212
- PubMed:22779176
- PubMed:22777226
- PubMed:22772611
- PubMed:22747347
- PubMed:22693913
- PubMed:22675394
- PubMed:22675387
- PubMed:22675033
- PubMed:22645576
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 286.5 °C at 1.00E+02 mm Hg Source: DrugBank
- Boiling Point: 357.1 °C; 287 °C at 100 mm Hg Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: BP: 365 °C (decomposes) Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: Distills above 360 °C with partial anhydride formation. BP: 286.5 °C at 100 mm Hg; 265 °C at 50 mm Hg; 237 °C at 15 mm Hg; 225 dg C at 10 mm Hg Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Monoclinic prismatic needles Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Yellowish to white crystalline powder Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Leaflets or needles Source: Hazardous Substances Data Bank (HSDB)
- Density: 1.225 g/cu cm at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- pKa: 4.55 (at 25 °C) Source: DrugBank
- Dissociation Constants: pKa = 4.55 Source: Hazardous Substances Data Bank (HSDB)
- Flash Point: 210 °C (closed cup) Source: Hazardous Substances Data Bank (HSDB)
- LogP: 1.57 Source: DrugBank
- LogP: log Kow = 1.57 Source: Hazardous Substances Data Bank (HSDB)
- LogP: 1.57 Source: Human Metabolome Database (HMDB)
- Melting Point: 106.5 °C Source: DrugBank
- Melting Point: 160.5 °C Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: 106.5 °C Source: Human Metabolome Database (HMDB)
- Physical Description: Dry Powder; Other Solid; Large Crystals Source: EPA Chemical Data Reporting (CDR)
- Physical Description: Yellowish to white solid; [HSDB] White flakes; [Acros Organics MSDS] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: Solid Source: Human Metabolome Database (HMDB)
- Refractive Index: Index of refraction = 1.4303 at 111 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: 2400 mg/L (at 20 °C) Source: DrugBank
- Solubility: Slightly soluble in ethy ether, benzene, DMSO; soluble in ethanol Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in hot water, alcohol and organic solvents Source: Hazardous Substances Data Bank (HSDB)
- Solubility: One liter of water dissolves 1.0 g at 1.0 °C; 2.4 g at 20 °C; 8.2 g at 50 °C; 22 g at 50 °C ... 1000 g ether dissolves 18.8 g at 11 °C and 26.8 g at 15 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: In water, 2.40X10+3 mg/L at 20 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: 2.4 mg/mL Source: Human Metabolome Database (HMDB)
- Vapor Pressure: 0.00000001 [mmHg] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: 1.07X10-8 mm Hg at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Source: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Approximately 4% of the topically applied azelaic acid is systemically absorbed. Source: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (71 of 1087) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Warning Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (40.2%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (93.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 1087 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 71 of 1087 reports by companies.; There are 11 notifications provided by 1016 of 1087 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Source: Cosmetic Ingredient Review (CIR)
- Toxicity Summary: The exact mechanism of action of azelaic acid is not known. It is thought that azelaic acid manifests its antibacterial effects by inhibiting the synthesis of cellular protein in anaerobic and aerobic bacteria, especially Staphylococcus epidermidis and Propionibacterium acnes. In aerobic bacteria, azelaic acid reversibly inhibits several oxidoreductive enzymes including tyrosinase, mitochondrial enzymes of the respiratory chain, thioredoxin reductase, 5-alpha-reductase, and DNA polymerases. In anaerobic bacteria, azelaic acid impedes glycolysis. Along with these actions, azelaic acid also improves acne vulgaris by normalizing the keratin process and decreasing microcomedo formation. Azelaic acid may be effective against both inflamed and noninflamed lesions. Specifically, azelaic acid reduces the thickness of the stratum corneum, shrinks keratohyalin granules by reducing the amount and distribution of filaggrin (a component of keratohyalin) in epidermal layers, and lowers the number of keratohyalin granules. Source: Toxin and Toxin Target Database (T3DB)
- Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for 1,7-heptanecarboxylic acid(SRC), using a log Kow of 1.57(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to have moderate mobility in soil(SRC). The pKa of 1,7-heptanecarboxylic acid is 4.55(4), indicating that this compound will exist almost entirely in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization from moist soil is not expected because the acid exists as an anion and anions do not volatilize. 1,7-Heptanecarboxylic acid is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.07X10-8 mm Hg(6). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(7). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to adsorb to suspended solids and sediment(SRC). A pKa of 4.55(4) indicates 1,7-heptanecarboxylic acid will exist almost entirely in the anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(8). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 1,7-heptanecarboxylic acid, which has a vapor pressure of 1.07X10-8 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase 1,7-heptanecarboxylic acid is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 40 hrs(SRC), calculated from its rate constant of 9.8X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase 1,7-heptanecarboxylic acid may be removed from the air by wet or dry deposition(SRC). 1,7-Heptanecarboxylic acid does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)
- Consumer Uses: Not Known or Reasonably Ascertainable Source: EPA Chemical Data Reporting (CDR)
- Industry Uses: Monomers; Lubricating agent; Wetting agent (non-aqueous); Binder; Intermediate; Not Known or Reasonably Ascertainable; Corrosion inhibitor; Plasticizer Source: EPA Chemical Data Reporting (CDR)
- Cosmetic Ingredient Review Link: CIR ingredient: Azelaic Acid Source: Cosmetic Ingredient Review (CIR)
- Sources/Uses: Found in rancid oleic acid; [Merck Index] Used in organic syntheses, lacquers, alkyd resins, low-temperature plasticizers, adhesives, polyamides, urethane elastomers, and for the treatment of acne; [HSDB] Natural component of foods such as whole grain cereals and animal products; [REPROTOX] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Azelaic acid is used in lacquers, alkyd resins, plasticizers, adhesives, polyamides, urethane elastomers, and organic syntheses. Azelaic acid is also used in treating of acne. Source: Hazardous Substances Data Bank (HSDB)
- Uses: Organic synthesis, lacquers, product of hydrotropic salts, alkyd resins, polyamides, polyester adhesives, low-temperature plasticizers, urethane elastomers Source: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >1000; Consumption (g per capita; approx.) in Germany (2009): 0.0122; Calculated removal (%): 92.2 Source: NORMAN Suspect List Exchange
- Uses: For the topical treatment of mild-to-moderate inflammatory acne vulgaris. Source: Toxin and Toxin Target Database (T3DB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Azelaic acid, disodium salt
- Nom IUPAC
- disodium;nonanedioate
- Formule moléculaire
- C9H14Na2O4
- Masse moléculaire
- 232.18 g/mol
- Masse exacte
- 232.06874749 Da
- Surface polaire topologique
- 80,3 Ų
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Unités covalentes
- 3
- Stéréocentres définis
- 0
Également connu sous le nom de
3 autres noms signalés
Identifiants de bases de données externes
- EPA DTXSID:DTXSID40889659
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Azelaic acid, dipotassium salt
- Nom IUPAC
- dipotassium;nonanedioate
- Formule moléculaire
- C9H14K2O4
- Masse moléculaire
- 264.40 g/mol
- Masse exacte
- 264.01662189 Da
- Surface polaire topologique
- 80,3 Ų
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Unités covalentes
- 3
- Stéréocentres définis
- 0
Également connu sous le nom de
5 autres noms signalés
Identifiants de bases de données externes
- EPA DTXSID:DTXSID501014948
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Recherche complémentaire sur la substance auprès de sources faisant autorité
Chaque lien lance une recherche de cette identité dans la source concernée. Un lien est une piste de recherche, et non l’affirmation que la source détient une fiche exacte. Ce qu’est chaque source et sa valeur juridique
Aller plus loin avec cette fiche
Source officielle et champ d’application
Importé de la décision d’exécution (UE) 2025/1175 de la Commission (version du jeu de données EU 2025/1175). Le glossaire fournit les dénominations communes des ingrédients pour la liste d’ingrédients exigée par l’article 19, paragraphe 1, point g) ; ce n’est ni une liste d’autorisation ni une liste de sécurité.
Ouvrir la décision officielle